FDA Drugs recall ·
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg… recall
- Recall number
- D-0742-2026
- Date
- (initiated June 26, 2026)
- Company / brand
- Bionpharma Inc.
400 Alexander Park Ste 2-4b, Princeton, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- N/A
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Why was it recalled?
Presence of Foreign Tablets/Capsules
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot# 704C003, Exp. 12/31/2028
Distribution
US Nationwide.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0742-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.